Allergic Rhinitis in China: Trends, Challenges and Implications Over the Past Two Decades
Clinical & Experimental Allergy · 2025-08 · 55 (8) · 648-658
DOI: 10.1111/cea.70118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 17.07.2025. Verfasst von Nan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Ch…. Hauptthemen laut MEDLINE: Rhinitis, Allergic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Hubei Provincial Key Research and Development Projects, Incubation Project for Medical Innovation and Transformation of Tongji Hospital.
Abstract (Originalsprache)
Allergic rhinitis (AR), as a common and challenging‐to‐cure allergic upper respiratory disease, poses severe health and economic burdens globally, including in China. Over the past two decades, the significant environment and lifestyle changes resulting from rapid socio‐economic development and urbanisation had a profound impact on the onset and progression of AR in China. This review examines the epidemiological trends in China. Specifically, the regional variation in allergen sensitisation patterns, the changes of these patterns over the past two decades, and the implications of these changes for disease prevention and diagnosis are discussed. We also outline the effects of indoor and outdoor air pollution on AR development, along with exploring corresponding solutions. Allergen immunotherapy (AIT) is recommended as the first‐line treatment for AR in China, and this review provides an overview of its current application, recent advancements, and remaining challenges in its implementation. Notably, biological therapies, administered as monotherapy or combined with AIT, are discussed in light of their revolutionary impact on AR management. Overall, this review highlights the trends and challenges of AR in China over the past two decades, along with their implications for disease prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Clinical Research Center for Nasal Inflammatory Diseases, Wuhan, China.
- Institute of Allergy and Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Nan Wang, Yin Yao, Yin-Hao Liu, Ming Zeng, Zheng Liu
Förderung
- National Key Research and Development Program of China
- Hubei Provincial Key Research and Development Projects
- Incubation Project for Medical Innovation and Transformation of Tongji Hospital
- National Natural Science Foundation of China grants
Zitieren
APA
Wang, N., Yao, Y., Liu, Y. H., Zeng, M., & Liu, Z. (2025). Allergic Rhinitis in China: Trends, Challenges and Implications Over the Past Two Decades. Clinical & Experimental Allergy, 55(8), 648-658. https://doi.org/10.1111/cea.70118
Vancouver
Wang N, Yao Y, Liu YH, Zeng M, Liu Z. Allergic Rhinitis in China: Trends, Challenges and Implications Over the Past Two Decades. Clinical & Experimental Allergy. 2025;55(8):648-658. doi:10.1111/cea.70118
BibTeX
@article{Wang2025,
author = {Wang, Nan and Yao, Yin and Liu, Yin-Hao and Zeng, Ming and Liu, Zheng},
title = {Allergic Rhinitis in China: Trends, Challenges and Implications Over the Past Two Decades},
journal = {Clinical & Experimental Allergy},
year = {2025},
volume = {55},
number = {8},
pages = {648--658},
doi = {10.1111/cea.70118}
}
EUVIMED